Durable benefit after treatment of obstructive benign prostatic hyperplasia with a novel drug-device combination product: 2-year outcomes from the EVEREST-I study.

Merycarla PichardoEdwin RijoGustavo EspinoRamon Rodriguez LayRafael EstrellaCristian GonzalezMarlin FernandezDavid SorianoIngris M PeraltaSteven A Kaplan

Published in: World journal of urology (2023)

NCT03423979, registered February 6, 2018.

Keyphrases

benign prostatic hyperplasia

lower urinary tract symptoms

emergency department